Assenagon Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-809,923
| Closed | -$12.7M | – | 1516 |
|
|
2024
Q1 | $12.7M | Hold |
809,923
| – | – | 0.03% | 372 |
|
|
2023
Q4 | $13.1M | Hold |
809,923
| – | – | 0.04% | 384 |
|
|
2023
Q3 | $10.3M | Sell |
809,923
-38,709
| -5% | -$534K | 0.04% | 375 |
|
|
2023
Q2 | $11.9M | Hold |
848,632
| – | – | 0.05% | 323 |
|
|
2023
Q1 | $13.1M | Sell |
848,632
-167,447
| -16% | -$2.8M | 0.05% | 320 |
|
|
2022
Q4 | $16.7M | Sell |
1,016,079
-387,742
| -28% | -$6.31M | 0.07% | 280 |
|
|
2022
Q3 | $26M | Buy |
1,403,821
+699,071
| +99% | +$11M | 0.11% | 204 |
|
|
2022
Q2 | $9.27M | Sell |
704,750
-150,949
| -18% | -$1.67M | 0.04% | 386 |
|
|
2022
Q1 | $7.93M | Buy |
855,699
+611,334
| +250% | +$5.2M | 0.03% | 426 |
|
|
2021
Q4 | $2.39M | Buy |
244,365
+219,874
| +898% | +$4.13M | 0.01% | 754 |
|
|
2021
Q3 | $832K | Sell |
24,491
-1,483
| -6% | -$47.3K | ﹤0.01% | 950 |
|
|
2021
Q2 | $951K | Buy |
+25,974
| New | +$1.01M | ﹤0.01% | 923 |
|
